Maxine Bauzon

This inventor holds 12 USPTO granted patents and 16 published patent applications, plus 4 CIPO patents and 9 EPO patents. Top assignees: Gladiator Biosciences, Inc., Bayer Healthcare LLC, Coagulant Therapeutics Corporation. Active years: 2014-2026.

USPTO Granted Patents = 12 (Patent Applications = 16)

% Patents Active = 83.3

CIPO Patents = 4 (Patent Applications = 13)

EPO Patents = 9 (Patent Applications = 24)

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 7(Granted Patents)

Company Filing History:

5 out of 5

Gladiator Biosciences, Inc.

Coagulant Therapeutics Corporation

patents

4. 1 out of 2

Ares Capital Corporation, as Collateral Agent

patents

5. 1 out of 125

R.p.scherer Technologies, Inc.

patents

Years Active: 2014-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12678481 - GLA DOMAINS AS THERAPEUTIC AGENTS (2026-07-14),

2. 12595314 - Antibody Specific for GPC3 and Methods of Use Thereof (2026-04-07),

3. 12527836 - GLA DOMAINS AS TARGETING AGENTS (2026-01-20),

4. 11981723 - Method of targeting exosomes (2024-05-14),

5. 11970546 - Antibody specific for Mucin-1 and methods of use thereof (2024-04-30),

6. 11530401 - Short-acting Factor VII polypeptides (2022-12-20),

7. 10925926 - GLA domains as therapeutic agents (2021-02-23),

8. 10894075 - Gla domains as targeting agents (2021-01-19),

9. 10717970 - Short-acting factor VII polypeptides (2020-07-21),

10. 10273466 - Short-acting factor VII polypeptides (2019-04-30),

11. 9694048 - Gla domains as targeting agents (2017-07-04),

12. 8882484 - Methods and compositions for production of recombinant protein in HBX-expressing mammalian cells (2014-11-11),

Title: Maxine Bauzon: Innovator in Biomedicine

Introduction

Maxine Bauzon is a prominent inventor based in Hercules, California. She has made significant contributions to the field of biomedicine, holding a total of 12 patents. Her work focuses on innovative methods and compositions that have the potential to enhance therapeutic responses in various medical applications.

Latest Patents

Among her latest patents is a method of targeting exosomes, which involves employing a molecule comprising a GLA domain and extracellular vesicles. This method aims to improve the targeting of extracellular vesicles for therapeutic purposes. Another notable patent is for antibodies specific for Mucin-1, which includes methods of use and compositions that incorporate these antibodies. These antibodies are designed to enhance immune responses, particularly in individuals with cell proliferative disorders. The patents also cover diagnostic and monitoring applications, showcasing the versatility of her inventions.

Career Highlights

Maxine has worked with notable companies in the biopharmaceutical sector, including Bayer Healthcare LLC and Gladiator Biosciences, Inc. Her experience in these organizations has allowed her to collaborate on groundbreaking research and development projects that push the boundaries of medical science.

Collaborations

Throughout her career, Maxine has collaborated with esteemed colleagues such as Terry Hermiston and David Rabuka. These partnerships have fostered an environment of innovation and have contributed to the success of her projects.

Conclusion

Maxine Bauzon's contributions to biomedicine through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in therapeutic methods and compositions.